IRIS
LAI, PIERO LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.580
Totale 6.580
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.580
Totale 6.580
Salva come PNG Salva come JPEG
Città #
Genova 5.020
Rapallo 941
Genoa 592
Bordighera 27
Totale 6.580
Salva come PNG Salva come JPEG
Nome #
Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines 144
Age-related differences in the accuracy of web query-based predictions of influenza-like illness 140
A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? 136
Do the omeprazole family compounds exert a protective effect against influenza-like illness? 136
Safety and tolerability of bivalent HPV vaccine: an Italian post-licensure study 134
Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly 132
Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy 128
Cost-benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria 125
An overview on the implementation of HPV vaccination in Europe 122
Burden of the 1999-2008 seasonal influenza epidemics in Italy: comparison with the H1N1v (A/California/07/09) pandemic. 119
Influenza vaccination: from epidemiological aspects and advances in research to dissent and vaccination policies 119
Cause of death among people with AIDS in Liguria (Italy). A different pattern for intravenous drug users? 118
Neisseria meningitidis B vaccines 117
Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies 117
Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? 115
A comprehensive analysis of Italian web pages mentioning squalene-based influenza vaccine adjuvants reveals a high prevalence of misinformation 112
Long-term decline of (137)Cs concentration in honey in the second decade after the Chernobyl accident 110
An overview of current and potential use of information and communication technologies for immunization promotion among adolescents 108
Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study 105
Neisseria meningitidis B vaccines: recent advances and possible immunization policies. 104
Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy 104
Chlamydia trachomatis prevalence and chlamydial/ HPV co-infection among HPV-unvaccinated young Italian females with normal cytology 100
Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V® and Fluad®) in preventing hospitalization for influenza and pneumonia in the elderly. A matched case-control study 96
Influenza Burden on Italian Paediatric Population: Five year Nation-wide Surveillance and Correlation between Epidemiological and Virological Data 94
Influenza epidemiology in Italy two years after the 2009-2010 pandemic: Need to improve vaccination coverage 89
Influenza epidemiology in Italy two years after the 2009-2010 pandemic: Need to improve vaccination coverage. 88
Valutazione della tollerabilità del vaccino anti-HPV nelle donne liguri 87
Benefit-cost evaluation of Influenza vaccination in the elderly in the Italian Region of Liguria 87
How the knowledge of interactions between meningococcus and the human immune system has been used to prepare effective Neisseria meningitidis vaccines 82
Development of a sensitive real-time PCR for simultaneous detection and subtyping of influenza A and B viruses 80
Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review 80
Virological investigation on aerosol from waste depuration plants 79
Relevance of air condititioning for 222Radon concentration in commercial concerns of the Savona Province, Italy 79
Heterogeneous estimates of influenza virus types A and B in the elderly: Results of a meta-regression analysis 79
VIROLOGICAL SURVEILLANCE AS A TOOL FOR ASSESSING HUMAN PAPILLOMAVIRUS VACCINATION 78
NEW VERSUS OLD MENINGOCOCCAL GROUP B VACCINES: HOW THE NEW ONES MAY BENEFIT INFANTS & TODDLERS 78
Utility of virosomal adjuvated influenza vaccines - a review of the literature. 77
Weekly monitoring of Influenza Like Illness (ILI) and other acute respiratory infections (ARI) impact on pediatric population during the last two years in 10 Italian Regions. 77
Anamnestic response to administration of purified non-adsorbent hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres. 77
Burden of rotavirus associated and non-rotavirus-associated diarrhea among nonhospitalized individuals in central Italy: a 1-year sentinel-based epidemiological and virological surveillance 77
Prevalence of the Human Papillomavirus genotypes in Italian women undergoing voluntary cervical cancer screening: Evaluation of cumulative incidence from 16 to 26 years of age and evaluationof the effect of extending Italian vaccination policy with bivalent vaccine. 76
Relevance of main factor affecting Radon concentration in multi-storey buildings in Liguria (Northern Italy) 74
People living with undiagnosed HIV infection and a low CD4 count: Estimates from surveillance data, Italy, 2012 to 2014 74
La vaccinazione universale dei bambini contro l’influenza con il vaccino Vaxigrip Tetra® in Italia: risultati di una valutazione di Health Technology Assessment (HTA) [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment] 72
Benefit-cost evaluation of Influenza vaccination in elderly people in Liguria, Italy 70
Neisseria meningitidis: pathogenetic mechanisms to overcome the human immune defences 70
Influenza surveillance by general practitioners and paediatricians in the Italian region of Liguria in 1999-2002 70
Tubercolosis today: populations at risk 70
PREVALENZA DEI TIPI DI HPV NELLE DONNE ITALIANE (16-26 ANNI) SOTTOPOSTE A SCREENING VOLONTARIO DEL CANCRO CERVICALE. VALUTAZIONE DELL’INCIDENZA CUMULATIVA E DELLA POSSIBILE ESTENSIONE DELLA VACCINAZIONE CON IL VACCINO BIVALENTE. 68
Live attenuated influenza vaccine-a review 66
Aflunov: a prepandemic influenza vaccine 66
Why the anti-meningococcal b vaccination during adolescence should be implemented in italy: An overview of available evidence 66
Valutazione costi-benefici della vaccinazione influenzale in Liguria 64
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: influenza life-cycle and currently available drugs 64
Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO®) 64
Hepatitis B immunization and anti-HBs quantitation: comparative performance of thirteen commercial immunoassays 63
Assessment and prevention of radioactive risk due to 222Radon in commercial concerns of Genoa 63
A pharmacoeconomic appraisal of the strategy to tackle the H1N1v (A/California/07/09) pandemic in Italy: relevance of the CIRI-IV surveillance system. 63
Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra® 62
Vaccination promotion within a framework of public health education 60
Diminuzione delle coperture vaccinali per influenza: riflessi sull'epidemiologia stagionale 2012-13 in Liguria. 60
In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains 60
Tobacco smoking among students in an urban area in Northern Italy 56
Le vaccinazioni dell'adulto a rischio e dell'anziano 54
Valutazione costi/benefici della vaccinazione influenzale negli anziani in Liguria (Italia) 53
Influenza vaccination in italian healthcare workers (2018–2019 season): Strengths and weaknesses. results of a cohort study in two large italian hospitals 51
EPIDEMIOLOGIA DELL’INFLUENZA IN ITALIA DOPO LA PANDEMIA 2009-10. NECESSITÀ DI MIGLIORARE LE COPERTURE VACCINALI. 50
Burden dell’influenza nella popolazione italiana nel periodo compreso tra il 1999 e il 2004: correlazioni tra sorveglianza clinico-epidemiologica e caratterizzazione antigenica e molecolare dei virus influenzali 49
Vaccinations for adults at risk and the elderly 49
Health Technology Assessment e vaccinazioni in Italia 49
Today's influenza vaccines. Why an adjuvant is needed and How it works 48
Efficacia dei vaccini adiuvati e ricadute farmaco-economiche 46
The urban myth of the association between neurological disorders and vaccinations. 46
Influenza vaccination of elderly: relaunch time 46
HTA in vaccine prevention: application to vaccinations against invasive diseases. 43
Meningococcal B vaccination strategies and their practical application in Italy 42
Influenza surveillance in the Italian region of Liguria in the winter of 1999-2000 by general practitioners and paediatricians: socio-economic implications 39
Influenza vaccination coverage in Italy in 1999-2013: impact on incidence of ILIs in the elderly. 37
UTILIZZO DELL'HTA IN PREVENZIONE VACCINALE: APPLICAZIONE ALLE VACCINAZIONI CONTRO LE MALATTIE INVASIVE 36
Health Technology Assessment (HTA) of the introduction of additional cohorts for anti-meningococcal vaccination with quadrivalent conjugate vaccines in Italy 35
Valutazione dell'impatto epidemiologico, sanitario ed aconomico della malattia da herpes zoster in Italia 34
Valutazione della copertura antinfluenzale in Liguria mediante somministrazione di questionario telefonico 32
Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy 32
Burden of typhoid fever and cholera: Similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas 29
Prevalenza dell’anti-HCV in pazienti plurioperati 27
Demographic and Socio-economic Determinants of Poor HIV-risk Perception at First HIV Diagnosis: Analysis of the HIV Surveillance Data, Italy 2010-2016 27
Implementazione dei tassi di copertura vaccinale antinfluenzale nel personale sanitario dell'A.U.O. San Martino di Genova durante la stagione 2005-06 23
Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59®-adjuvanted influenza vaccine in older adults: Results from three consecutive seasons 22
No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020 20
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0] 13
The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment 10
Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season 4
Three seasons of enhanced safety surveillance of a cell culture-based quadrivalent influenza vaccine 3
Totale 6.699
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.308
article - articoli 16.284
book - libri 0
conference - conferenze 2.806
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 218
Totale 38.616
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019213 0 0 0 0 0 0 0 0 0 0 117 96
2019/20201.733 41 23 78 68 138 195 256 103 173 359 210 89
2020/2021406 24 22 32 25 53 40 22 26 39 41 43 39
2021/2022988 21 97 74 96 48 45 55 249 62 77 41 123
2022/20231.125 108 81 16 105 172 208 4 76 172 6 164 13
2023/2024451 18 84 12 75 34 92 34 55 40 7 0 0
Totale 6.699